Role of Nucleophosmin Mutations in AML

被引：0
|
作者：
Funato, Kotaro [1 ]
Sternberg, David W. [1 ]
机构：
[1] Mt Sinai Sch Med, Div Hematol Oncol, New York, NY USA
来源：
BLOOD | 2008年 / 112卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1346 / 1346
页数：1
相关论文
共 50 条
  • [1] Nucleophosmin Mutations in AML: A Retrospective Study
    Best, H.
    Jagasia, M.
    Vnencak-Jones, C. L.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2008, 10 (06): : 584 - 584
  • [2] The incidence and clinical significance of nucleophosmin mutations in childhood AML
    Brown, Patrick
    McIntyre, Emily
    Rau, Rachel
    Meshinchi, Soheil
    Lacayo, Norman
    Dahl, Gary
    Alonzo, Todd A.
    Chang, Myron
    Arceci, Robert J.
    Small, Donald
    BLOOD, 2007, 110 (03) : 979 - 985
  • [3] Carboxyterminal nucleophosmin insertion mutations in AML are detected efficiently by DHPLC
    Nollet, F.
    Billiet, J.
    Verduyn, J.
    Selleslag, D.
    Van Hoof, A.
    Van Droogenbroeck, J.
    Hidajat, M.
    Criel, A.
    ACTA CLINICA BELGICA, 2006, 61 (02): : 109 - 109
  • [4] Molecular roulette: nucleophosmin mutations in AML are orchestrated through N-nucleotide addition by TdT
    Borrow, Julian
    Dyer, Sara A.
    Akiki, Susanna
    Griffiths, Michael J.
    BLOOD, 2019, 134 (25) : 2291 - 2303
  • [5] Incidence and clinical significance of nucleophosmin mutations in childhood AML: A Childrens Oncology Group study.
    Brown, Patrick
    McIntyre, Emily
    Rau, Rachel
    Alonzo, Todd A.
    Gerbing, Robert
    Meshinchi, Soheil
    Lacayo, Norman
    Chang, Myron
    Arceci, Robert
    Small, Donald
    BLOOD, 2006, 108 (11) : 69A - 70A
  • [6] Rapid method for detection of mutations in the nucleophosmin gene (NPM1) in acute myeloid leukemia (AML)
    Laughlin, T. S.
    Beckerz, M. W.
    Liesveld, J. L.
    Mulford, D. A.
    Abboud, C. N.
    Rothberg, P. G.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2007, 9 (05): : 670 - 671
  • [7] ROLE OF MUTATIONS IN EPIGENETIC REGULATORS IN THE PATHOGENESIS OF AML
    Levine, Ross
    EXPERIMENTAL HEMATOLOGY, 2017, 53 : S38 - S38
  • [8] CYTOPLASMIC NUCLEOPHOSMIN (NPMC) DETECTION BY FLOW CYTOMETRY AS SURROGATE FOR THE PRESENCE OF NPM1 MUTATIONS IN PATIENTS WITH AML
    Oelschlaegel, Uta
    Koch, Sina
    Schaich, Markus
    Kroschinsky, Frank
    Parmentier, Stefani
    Ehninger, Gerhard
    Thiede, Christian
    CYTOMETRY PART B-CLINICAL CYTOMETRY, 2009, 76B (06) : 413 - 413
  • [9] Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML
    Martelli, Maria Paola
    Rossi, Roberta
    Venanzi, Alessandra
    Meggendorfer, Manja
    Perriello, Vincenzo Maria
    Martino, Giovanni
    Spinelli, Orietta
    Ciurnelli, Raffaella
    Varasano, Emanuela
    Brunetti, Lorenzo
    Ascani, Stefano
    Quadalti, Corinne
    Cardinali, Valeria
    Mezzasoma, Federica
    Gionfriddo, Ilaria
    Milano, Francesca
    Pacini, Roberta
    Tabarrini, Alessia
    Bigerna, Barbara
    Albano, Francesco
    Specchia, Giorgina
    Vetro, Calogero
    Di Raimondo, Francesco
    Annibali, Ombretta
    Avvisati, Giuseppe
    Rambaldi, Alessandro
    Falzetti, Franca
    Tiacci, Enrico
    Sportoletti, Paolo
    Haferlach, Torsten
    Haferlach, Claudia
    Falini, Brunangelo
    BLOOD, 2021, 138 (25) : 2696 - 2701
  • [10] PROGNOSTIC SIGNIFICANCE OF NUCLEOPHOSMIN AND FLT3 GENES MUTATIONS IN EGYPTIAN CHILDHOOD ACUTE MYELOBLASTIC LEUKEMIA (AML)
    El-Fadaly, Nabih
    Saeed, Shebl
    El Shanshory, Mohamed
    Amer, Eman
    El-Fadaly, Rasha
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2013, 35 : 90 - 90
12345